Orligal
$ 13,00 – $ 42,00Price range: $ 13,00 through $ 42,00
P-Force
$ 30,00 – $ 95,00Price range: $ 30,00 through $ 95,00
Ortho Tri-Cyclen
$ 28,00 – $ 56,00Price range: $ 28,00 through $ 56,00
Ortho Tri-Cyclen is a highly effective triphasic oral contraceptive designed to prevent pregnancy by utilizing a combination of norgestimate and ethinyl estradiol. This daily medication works primarily by inhibiting ovulation and altering cervical mucus to ensure reliable protection. In addition to its primary use, it is clinically proven to treat moderate acne in women who choose to use hormonal contraception for clearer skin. Users often benefit from more predictable and manageable menstrual cycles while following the consistent monthly pill regimen. This dual-action formula provides a convenient and well-established option for managing both reproductive health and complexion concerns.
Active substance: Ethinyl estradiol, Norgestimate
SKU:
Ortho Tri-Cyclen
Category: Birth Control
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Ortho Tri-Cyclen belongs to a group of medicines called combined oral contraceptives, which contain a synthetic estrogen and a progestin. This prescription medication is formulated with ethinyl estradiol and norgestimate delivered in a triphasic dosing schedule over a 28-day cycle.
It is approved by the U.S. Food and Drug Administration (FDA) primarily for preventing pregnancy in females of reproductive potential. In addition, it is indicated for treating moderate acne vulgaris in females who are at least 15 years old, have achieved menarche, and desire oral contraception.
| Attribute | Product Details |
|---|---|
| Drug name | Ortho Tri-Cyclen |
| Active ingredient (INN) | Ethinyl estradiol, norgestimate |
| Therapeutic class | Estrogen and progestin combination contraceptive |
| Dosage form | Oral tablet |
| Route of administration | Oral |
| Prescription status | Prescription (Rx) only |
| Primary purpose | Pregnancy prevention and moderate acne management |
How the drug works
Ortho Tri-Cyclen acts primarily by suppressing gonadotropins, which inhibits ovulation during the menstrual cycle. The progestin component, norgestimate, alters cervical mucus to impede sperm penetration into the uterine cavity. Simultaneously, it induces endometrial changes that reduce the likelihood of successful blastocyst implantation. The ethinyl estradiol component helps stabilize the uterine lining to maintain menstrual cycle control. When evaluated for acne management, the combined hormonal action decreases circulating free testosterone levels by elevating sex hormone-binding globulin (SHBG) synthesis in the liver and inhibiting 5-alpha-reductase activity, which ultimately reduces sebum production on the skin.
Main uses
The primary FDA-approved indication for Ortho Tri-Cyclen is the prevention of pregnancy in females who choose to use oral contraceptives as a primary method of family planning. When taken correctly without missed pills, combined oral contraceptives demonstrate high clinical efficacy in preventing unintended pregnancies. The secondary FDA-approved indication is the treatment of moderate acne vulgaris in females who are at least 15 years of age. For acne treatment, candidates must have reached menarche, have no known contraindications to oral contraceptive therapy, and desire an oral contraceptive for birth control. Compared with dedicated topical or systemic acne treatments, using this medication solely for acne without a requirement for contraception is not indicated.
What happens in the body
Both active components are absorbed rapidly following oral administration. Norgestimate undergoes extensive first-pass hepatic and gastrointestinal metabolism to its primary active metabolites, deacetylnorgestimate and norgestrel. Peak plasma concentrations of deacetylnorgestimate are achieved within 1 to 2 hours after ingestion. Ethinyl estradiol is also rapidly absorbed, reaching peak serum concentrations within 1 to 2 hours. The elimination half-life of deacetylnorgestimate averages approximately 12 to 30 hours, while ethinyl estradiol exhibits an elimination half-life ranging between 10 and 18 hours. Metabolic products are eliminated through both renal and biliary excretion pathways.
Dosing schedule
Ortho Tri-Cyclen is supplied in a 28-day regimen pack consisting of 21 active hormonal tablets and 7 inactive placebo tablets. Patients take one pill daily at approximately the same time every day to maintain consistent blood hormone levels. The triphasic regimen begins with 7 blue tablets containing 0.180 mg norgestimate and 0.035 mg ethinyl estradiol, followed by 7 cool-blue tablets containing 0.215 mg norgestimate and 0.035 mg ethinyl estradiol, and 7 dark-blue tablets containing 0.250 mg norgestimate and 0.035 mg ethinyl estradiol. The final 7 green tablets contain no active ingredients. Withdrawal bleeding typically occurs during the week of inactive green tablets.
If you skip a dose
Adherence to the daily dosing schedule is essential for maintaining contraceptive efficacy. On one hand, missing a single inactive green tablet requires no corrective action; on the other hand, missing active tablets increases the risk of ovulation. If one active tablet is missed in Weeks 1, 2, or 3, the tablet should be taken as soon as remembered, and the next tablet taken at the regular time, even if two tablets are taken on the same day. If two active tablets are missed sequentially in Week 1 or Week 2, the patient should take two tablets on the day remembered and two tablets the following day, while utilizing a non-hormonal back-up contraceptive method for 7 consecutive days. Specific instructions for Week 3 missed doses vary depending on whether a Sunday Start or Day 1 Start schedule is used.
Compatibility with other medicines
Co-administration of Ortho Tri-Cyclen with microsomal liver enzyme-inducing drugs can significantly diminish contraceptive efficacy and increase breakthrough bleeding. Significant drug interactions occur with broad-spectrum anticonvulsants such as carbamazepine, phenytoin, and topiramate, as well as antimicrobial agents like rifampin. Herbal products containing St. John’s wort (Hypericum perforatum) induce CYP3A4 enzymes, thereby accelerating hormone clearance. Certain HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors may also alter plasma hormone concentrations. Additionally, bile acid sequestrants such as colesevelam can decrease hormone absorption if taken simultaneously; therefore, administration should be separated by at least 4 hours.
What you may notice early on
During the initial 1 to 3 months of initiating Ortho Tri-Cyclen, the endocrine system adapts to exogenous hormone administration. Patients frequently observe minor breakthrough bleeding or spotting between scheduled menstrual cycles. Mild nausea, breast tenderness, and transient headache may also occur during early pill packs. These physiological adjustments generally resolve as the body adapts to the fixed daily regimen. For acne management, therapeutic improvements are typically gradual, often requiring 2 to 3 complete cycles before a noticeable clinical reduction in facial lesions occurs.
Adverse reactions
Common side effects associated with combined oral contraceptives include breakthrough bleeding, spotting, nausea, abdominal cramps, breast enlargement or tenderness, and minor fluid retention. Some patients report headache, mild mood changes, or contact lens intolerance. On one hand, these minor symptoms are generally self-limiting; on the other hand, serious vascular adverse events require immediate evaluation. The most critical risk associated with combined oral contraceptives is an elevated risk of venous thromboembolism (including deep vein thrombosis and pulmonary embolism) and arterial thromboembolism (including myocardial infarction and stroke).
Important precautions
Cigarette smoking significantly increases the risk of serious cardiovascular events in females who use combined oral contraceptives. This risk increases markedly with age, particularly in women over 35 years old, and with the quantity of cigarettes smoked daily. Consequently, Ortho Tri-Cyclen is contraindicated in women over 35 who smoke. It is also contraindicated in patients with a history of deep vein thrombosis, pulmonary embolism, active liver disease, uncontrolled hypertension, or known or suspected estrogen-dependent neoplasia. In special populations such as breastfeeding mothers, oral contraceptives containing estrogen may decrease milk production and alter milk composition; alternative methods are generally recommended during lactation.
What to avoid while taking it
Standard dietary intake does not alter the clinical absorption of Ortho Tri-Cyclen, meaning tablets may be taken with or without food. Taking the daily dose with meals or at bedtime can help reduce potential gastrointestinal upset or nausea. Alcohol consumption does not directly lower the pharmacological efficacy of the active hormones, but excessive alcohol use may lead to missed doses or irregular timing. Patients should avoid consuming large quantities of grapefruit juice, as grapefruit components can inhibit CYP3A4 enzymes and potentially increase systemic exposure to ethinyl estradiol.
Storage and expiration
Ortho Tri-Cyclen blister packs should be stored at controlled room temperature, between 20°C to 25°C (68°F to 77°F), with brief excursions permitted between 15°C and 30°C (59°F to 86°F). The product must be protected from excessive moisture, direct light, and high ambient heat. Keep all prescription blister packs out of the reach of children and pets. Do not use tablets past the expiration date printed on the packaging. Unused or expired medications should be disposed of via designated community take-back programs rather than flushed down household drains.
| Warning Sign | Action Required |
|---|---|
| Severe chest pain or shortness of breath | Seek emergency medical care immediately |
| Pain, swelling, or redness in one lower leg | Seek immediate medical evaluation |
| Sudden severe headache or visual disturbance | Discontinue pill and seek emergency care |
| Yellowing of the skin or eyes (jaundice) | Contact your healthcare provider promptly |
| Severe abdominal pain or tenderness | Seek immediate clinical evaluation |
Common questions
What should I do if I vomit or have severe diarrhea after taking a pill?
If vomiting or severe diarrhea occurs within 3 to 4 hours after taking an active tablet, the active hormones may not be fully absorbed. Treat this situation as a missed dose and follow the specific missed pill instructions based on your cycle week, using back-up contraception if necessary.
Does Ortho Tri-Cyclen cause permanent changes in fertility after stopping?
No. Returning to natural ovulatory cycles typically occurs within a few weeks to months after discontinuing combined oral contraceptives. Patients who had irregular cycles prior to starting birth control may return to their baseline pattern after stopping the medication.
How soon does Ortho Tri-Cyclen become effective at preventing pregnancy?
If started on the first day of your menstrual period (Day 1 Start), the medication is effective immediately. If started on the first Sunday after your period begins (Sunday Start), an additional non-hormonal back-up method of birth control (such as condoms) must be used for the first 7 consecutive days.
Is it safe to switch from another birth control pill to Ortho Tri-Cyclen mid-cycle?
Switching is typically done seamlessly by starting Ortho Tri-Cyclen on the day you would have started your new pack of the previous contraceptive. Consult your prescribing provider for exact timing to ensure continuous coverage without gaps in protection.
Can I take Ortho Tri-Cyclen to treat acne if I am not sexually active?
While Ortho Tri-Cyclen is FDA-approved for moderate acne management in qualified females, its clinical profile is designed for individuals who also desire oral contraception. Healthcare providers evaluate overall health risks, such as blood clot potential, before prescribing hormonal therapy solely for dermatological reasons.
In accordance with FDA requirements.
Information on this page is for reference and does not replace an assessment by a licensed healthcare professional.
Additional information
| Dosage |
0.05 mg + 0.03 mg |
|---|---|
| Package |
28 tabs ,56 tabs ,84 tabs |
| Ενεργός Ουσία | , |
Related products
Alesse
$ 65,00 – $ 208,00Price range: $ 65,00 through $ 208,00
Active substance: ethinyloestradiol, Levonorgestrel
More Details
This product has multiple variants. The options may be chosen on the product page
Durex Air Ultra Thin Condoms
$ 25,00 – $ 54,00Price range: $ 25,00 through $ 54,00
More Details
This product has multiple variants. The options may be chosen on the product page
Folic Acid
$ 6,00 – $ 18,00Price range: $ 6,00 through $ 18,00
Active substance: Folic Acid
More Details
This product has multiple variants. The options may be chosen on the product page
KamaSutra Longlast Condoms
$ 25,00 – $ 54,00Price range: $ 25,00 through $ 54,00
More Details
This product has multiple variants. The options may be chosen on the product page
KamaSutra Pink Dotted Condoms
$ 11,00 – $ 28,00Price range: $ 11,00 through $ 28,00
More Details
This product has multiple variants. The options may be chosen on the product page
Levlen
$ 40,00 – $ 96,00Price range: $ 40,00 through $ 96,00
Active substance: ethinyloestradiol, Levonorgestrel
More Details
This product has multiple variants. The options may be chosen on the product page
Plan B
$ 60,00 – $ 132,00Price range: $ 60,00 through $ 132,00
Active substance: Levonorgestrel
More Details
This product has multiple variants. The options may be chosen on the product page
Yaz
$ 15,00 – $ 40,00Price range: $ 15,00 through $ 40,00
Active substance: drospirenone, ethinylestradiol
More Details
This product has multiple variants. The options may be chosen on the product page
